Achieving and maintaining a healthy weight is beneficial for a number of reasons. A healthy weight lowers a person's chance ...

Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug ...

GLP-1 weight-loss drugs are cutting calories… and grocery bills, according to a new study from Cornell and Numerator.

Purchases of calorie-dense, processed items such as chips, baked goods and cookies were most affected, according to findings ...

How brands will alert consumers to their products' compatibility with GLP-1 drugs like Ozempic. Conagra Brands launches first ...

Nestlé released a similar announcement on September 18, 2024, revealing an entirely new line of GLP-1-friendly foods under ...

In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies ...

Eli Lilly’s request to intervene in a suit filed by compounding pharmacies against the FDA reflects a belief the outcome ...

Following rapid (and pricey) expansion efforts from Novo and Lilly, plus recent shortage updates at the FDA, “positive ...

Experts say patients should adjust dosage, try prescribed and over-the-counter drugs to help with symptom management and ...

GIP/GLP-1 Coagonist III is under clinical development by Eli Lilly and Co and currently in Phase I for Cardiometabolic Disease.

The U.S. Food and Drug Administration (FDA) has approved a generic daily injectable for the GLP-1 medication for patients who ...